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All treatment plans were met the clinically acceptable goals. 
The 4D-IMRT showed a statistically significant improvement 
(p<0.05) compared to 3D-IMRT in all relevant parameters. 
The 4D-VMAT plans further reduced all OAR parameters 
significantly (p<0.05), while maintaining identical target 
coverage. Phantom measurements confirmed that both 
techniques (IMRT and VMAT) can be safely administered.  
 
Conclusion: By using the 4D-CT acquisition and mid-
ventilation target delineation approach, significant PTV 
volume reduction was obtained. This method is improving 
PTV coverage and OAR doses using the same technique 
(IMRT). VMAT technique might further gain additional 
dosimetric benefits for patients with NSCLC.  
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Purpose or Objective: We applied a variety of published 
conventional and stereotactic plan quality dosimetric indices 
to describe and discern clinically achieved target dose 
distributions in Lung SBRT. 
 
Material and Methods: Treatment plans of 100 Lung SBRT 
patients treated were retrospectively reviewed. The targets 
(n=102) were evenly distributed – right lung (53) and left lung 
(49). Patients were prescribed to a total dose of 50-60 Gy in 
3-5 fractions. Dose optimizations were accomplished with 6 
MV using either 2-5 arcs VMAT (90); 8-14 IMRT fields (6) or 10-
16 static fields (6). Dose calculations were performed using 
AAA algorithm with heterogeneity correction. A literature 
review on dosimetric indices recommended for qualitative 
analyses of conventional and stereotactic dose distributions 
in target coverage, homogeneity, conformity and gradient 
categories was performed. From each patient treatment 
plan, the necessary parameters for calculating various indices 
were quantified. 
 
Results: For the study, the mean (±SD) values for indices 
were: coverage (96.4 (±2.4) %); homogeneity (1.27 (±0.07)); 
Conformity (1.04 (±0.08)) and Gradient 1.27(±0.30) cm). 
Geometric conformity (g) strongly correlated with the 
conformity index (defined by van’t Riet /Paddick)(p<0.0001). 
All Gradient measures strongly correlated with PTV 
(p<0.0001). Evaluating High Dose Spillage, the average 
cumulative volume of all tissue outside the PTV receiving a 
dose of > 105% of prescription dose was 0.94 (± 1.64) %. 
Considering Low Dose Spillage, the maximum % of 
prescription dose to any point at 2 cm distance in any 
direction from PTV was 56.0 (± 11.4) %. The lung volume 
(total lung volume – GTV) receiving doses of 20 Gy and 5 Gy 
(V20 and V5) were mean 4.9 % (± 3.1) and 16.9 % (± 9.0). The 
RTOG lung SBRT protocol advocated conformity guidelines for 
prescribed dose in all dosimetric evaluation categories were 
met in ≥94% of cases.  
 
Conclusion: The high-rate of adherence to RTOG protocol 
dose conformancy guidelines in our study validates that 
indices derived from our SBRT lung plan dose distributions 
are a tool for establishing plan metrics in clinical trials, for 
scoring competing plans and as well as for comparing inter-
institutional lung SBRT plan dosimetric data. However, these 
indices should only be used as an additional tool to grade 
plan quality once a satisfactory treatment plan has been 
achieved judged on the basis of clinical expertise, acceptable 
dose distributions and dose gradients, while respecting 
critical organ and normal structure doses. 
 
PO-0846  
The impact of anatomical changes on the accumulated 
carbon ion dose in pancreatic cancer patients 
A.C. Houweling
1Academic Medical Center, Department of Radiation 
Oncology, Amsterdam, The Netherlands 
1, K. Fukata2, Y. Kubota2, H. Shimada2, C.R.N. 
Rasch1, T. Ohno2, A. Bel1, A. Van der Horst1 
2Gunma University, Gunma University Heavy Ion Medical 
Center, Maebashi, Japan 
 
Purpose or Objective: Improvements in overall survival of 
pancreatic cancer patients after carbon ion radiotherapy 
have been reported from Japanese clinical trials. Due to the 
sharp distal dose fall-off, a high dose can be delivered to the 
tumor, while sparing the nearby healthy organs. However, 
changes in gastrointestinal gas volumes can greatly influence 
the carbon ion range. 
We evaluated the robustness of carbon ion therapy for 
pancreatic cancer patients by investigating the impact of 
interfractional anatomical changes on the accumulated dose 
when using bony anatomy- and fiducial marker-based position 
verification. 
 
Material and Methods: Nine pancreatic cancer patients, 
treated with photon radiotherapy in free breathing, were 
included in this retrospective planning study. The internal 
gross tumor volume (iGTV), internal clinical target volume 
(iCTV), duodenum, stomach, liver, spinal cord and kidneys 
were delineated on the (average) 4D-CT scan. Intratumoral 
gold fiducial markers were implanted in all patients to enable 
position verification using cone beam CT (CBCT). 
Treatment plans were created using a 4-beam passive 
scattering technique. A smearing technique was used to 
account for patient setup errors; a safety margin of 3 mm 
was applied to compensate for range uncertainties. Plans 
were generated to deliver at least 95% of the prescribed dose 
(36GyE in 12 fractions) to 99% of the iCTV. 
To enable dose calculations on the daily CBCTs, the planning 
CT was deformably registered to each CBCT. The 
gastrointestinal gas volume visible on each CBCT was copied 
to the deformed CTs. Next, fraction doses were calculated by 
aligning the treatment plan according to a bony anatomy- 
and a fiducial marker-based registration. For both 
registration methods the resulting fraction doses were rigidly 
summed to acquire the accumulated dose. 
We compared both accumulated doses to the planned dose 
using dose-volume histograms (DVHs) and calculated DVH 
parameters for the iGTV and iCTV (Dmean, D2%, D98%) and 
organs at risk (Dmean, D2cc). 
 
Results: The D98% of the target volumes showed the largest 
differences (Figure). For the bony anatomy-based 
registration, D98% reduced significantly from 99.6% ± 0.2% 
(iGTV; mean ± standard deviation) and 98.6% ± 0.5% (iCTV) as 
planned to 92.3% ± 3.8% and 81.9% ± 7.7% for the 
accumulated dose, respectively. For the marker-based 
registration, this was slightly improved to 95.1% ± 4.0% (iGTV) 
and 88.6% ± 4.0% (iCTV), which was still significantly 
different from planned. 
For the duodenum, severe deviations were observed in the 
DVHs between the planned and accumulated dose. Both the 
direction and magnitude of the deviations differed 
considerably between patients. The other organs showed 
minor changes. 
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Conclusion: Severe reductions in target dose coverage were 
observed as an effect of interfractional anatomical changes. 
The difference between the position verification methods 
was a lesser issue compared to the effect of the anatomical 
changes. 
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Purpose or Objective: The new ESTRO consensus guideline 
for target delineation for elective breast radiotherapy 
(Offersen Radiother Oncol. 2015) establish the humeral head 
and connective tissues 10 mm around it as Planning Risk 
Volume (PRV). The objective was to implement these 
guidelines for sparing the humeral head in elective breast 
radiotherapy with level 1 and 2 (L1/L2) lymph nodes by 
comparing three different planning techniques. 
 
Material and Methods: Ten patients with left-sided breast 
cancer were enrolled in a planning study performed in 
Pinnacle3 v9.8 (Philips). All patients were planned with 16 x 
2.66Gy on the breast (PTVp) and the elective L1/L2 lymph 
nodes (PTVn). We compared three techniques: IMRT with high 
tangential field (HTF), 6-field IMRT and VMAT. The humeral 
head PRV (hh+10) was included with an objective of V40Gy < 
1cc for all three techniques. Treatment plans were obtained 
with the inverse planning tool and optimization was achieved 
by decreasing the dose to the organs at risk (OARs; lungs, 
heart and right breast) as low as possible while maintaining a 
PTVp V95% of 97% and PTVn V90% of 95%.  
For the high tangential fields, the cranial border of the fields 
was extended to include PTVn. The leaves of the 5 mm multi 
leaf collimator were then closed to exclude hh+10 to reduce 
the dose to the humeral head and the surrounding tissue. 
This technique is currently used in our clinic. The 6-field 
IMRT technique consisted of tangential fields and four 
additional fields (at 330, 20, 80 and 170 degrees) to ensure 
proper coverage of the cranial part of the breast and the 
lymph nodes. The cranial border of the tangential fields and 
caudal border of the four additional fields was set 1cm below 
the attachment of the clavicle at the sternum. The third 
technique was a VMAT dualarc from 305 to 180 degrees.  
 
Results: HTF resulted in an average PTVp V95% of 97.2% and 
an average PTVn V90% of 90.4% (see Table 1). With the 
additional fields of the 6-field IMRT technique, the coverage 
of the lymph nodes increased significantly to on average 
98.0% (p = 0.01) while PTVp did not vary significantly (p = 
0.92). The doses to the OAR were comparable between the 
HTF and IMRT technique. The coverage of PTVn increased 
when using VMAT to an average of 99.5% (p < 0.01 compared 
to HTF and p = 0.19 compared to IMRT). The dose to the OAR 
increased as well. The mean dose to the contralateral breast 
increased significantly from 0.6Gy with HTF and IMRT to 
2.3Gy with VMAT (p < 0.01 for both). 
 
 
 
Conclusion: The humeral head and surrounding tissues as 
defined in the new ESTRO guideline can be spared with the 6-
field IMRT or VMAT technique. It is not possible through high 
tangential fields without reducing PTVn coverage.  
A 6-field IMRT technique including tangential fields and four 
additional fields to cover the lymph nodes and the cranial 
part of the breast leads to adequate coverage of the primary 
target and the lymph nodes without increasing the dose to 
the other OARs. 
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Purpose or Objective: Stereotactic radiotherapy near critical 
serial organs at risk (OAR) requires specific caution to avoid 
severe toxicity. Current strategies are to (1) to rule out SBRT 
as a treatment option, (2) to use full dose SBRT and expose 
patients to higher risks, (3) to homogenously underdose the 
entire planning target volume (PTV), or (4) to trim PTV 
margins individually and non-quantifiably. We here describe a 
novel IMRT prescription method termed simultaneous 
integrated protection (SIP) for quantifiable and comparable 
dose prescription to targets very close to dose limiting 
structures. This work will be focussed on the planning of 
SBRT. 
 
Material and Methods: For patients with infringement of 
dose constraints to at least one serial OAR, e.g. central 
airways, bowel, we defined a planning risk volume (PRV). The 
intersection volume of the PRV with the total planning target 
volume (PTV_Σ) was defined as the protection PTV_SIP and 
the vast non-intersecting majority of PTV_Σ as the dominant 
PTV (PTV_dom). Radiotherapy treatment planning was 
performed using IMRT. Dose was prescribed to PTV_dom 
according to ICRU in 3, 5, 8 or 12 fractions. If in doubt, 
preference to a higher number of fractions was given as a 
function of the size of PTV_SIP. D_max was allowed to be up 
to 130% of the prescribed dose. No specific dose was 
prescribed to the PTV_SIP but dose was required to stay just 
within the constraints for the respective OAR. Dose-volume-
histogram (DVH) analysis was based on absolute volumes of 
OARs, not on PRVs. 
 
Results: This method led to a fall off region within PTV_SIP 
between the PTV_dom and the OAR. We here demonstrate 
this approach for six patients. Two had lesions in the chest, 
one in the liver, two in the pancreas and one in the left 
kidney (Figure 1). Size of the PTVs (PTV_Σ) ranged from 14.5 
to 84.9 mL (median 49.2 mL, mean 49.7 mL; Figure 2). Sizes 
of PTV protection subvolumes (PTV_SIP) ranged from 1.8 – 3.9 
mL (median and mean 2.8 mL). Relative PTV_SIP ranged from 
2.9% - 13.4% of the size of PTV_Σ (median 7.4%). Noteworthy, 
the largest ratio, 13.4%, was an absolute volume of 2 mL, 
only. D_min of the PTV_SIP was significantly lower in patients 
